Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 23.39
-2.74 %
$ 1.08 B
Market Cap
-10.88
P/E
Price Target
Average
20.93%
Revenue Forecast
Estimate
7.43%
EBIT
Estimate
3.14%
Net Income
Estimate
79.33%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pacira BioSciences, Inc.
Wall Street analysts predict an average 1-year price target for PCRX of $28.3 , with forecasts ranging from
a
low of
$8 to a high of $57 .
PCRX Lowest Price Target
Wall Street Target
8 USD
-65.80%
PCRX Average Price Target
Wall Street Target
28.3 USD
20.93%
PCRX Highest Price Target
Wall Street Target
57 USD
143.69%
REVENUE FORECAST
Revenue Forecast Chart PCRX
EBIT FORECAST
EBIT Forecast Chart PCRX
NET INCOME FORECAST
Net Income Chart PCRX